Hearing Experts Launch Decibel Therapeutics for Drug Discovery

Third Rock Ventures LLC, a healthcare venture firm, has announced the launch of Decibel Therapeutics, with $52 million in financing by Third Rock and SR One, the corporate venture capital arm of GlaxoSmithKline, to discover new medicines that protect, repair, and restore hearing.